Medical Journals

Dopamine-mediated Actions of Ephedrine in the Rat Substantia Nigra.

Authors:
  • Munhall Adam C
  • Johnson Steven W

From: Department of Neurology, Oregon Health and Science University, Portland, OR 97239, USA.

Brain research

  • Publish Date: Jan 2006
  • ISSN: 0006-8993
  • Volume: 1069
  • Issue: 1
  • Pages: 96-103
  • Medium: Print
  • Language: English
  • Citation (JAMA): Munhall Adam C, Johnson Steven W, et al. Dopamine-mediated Actions of Ephedrine in the Rat Substantia Nigra.. Brain Res. Jan 2006;1069:96-103

Abstract

Although ephedrine is a centrally active stimulant, its effect on midbrain dopamine neurons is not known. To study the effect of ephedrine on dopamine-containing cells, current-clamp microelectrode recordings were made from substantia nigra pars compacta (SNC) neurons in horizontal brain slice preparations. Ephedrine (100-1000 microM) slowed spontaneous firing and produced a modest concentration-dependent hyperpolarization of membrane potential (EC50 279 microM), with a concomitant net decrease in membrane resistance. These effects were blocked by the D2-like dopamine antagonist sulpiride (1 microM). Electrically evoked inhibitory synaptic potentials mediated by GABAB receptors were reduced 28% by ephedrine. However, ephedrine did not reduce fast synaptic potentials mediated by GABAA or ionotropic glutamate receptors. Inhibition of the GABAB response appeared to be mediated by a postsynaptic mechanism because ephedrine also reduced baclofen-induced hyperpolarization by 28%. Both ephedrine-induced hyperpolarization and inhibition of baclofen-induced hyperpolarization were abolished when slices were superfused with the tyrosine hydroxylase inhibitor alpha-methyl-para-tyrosine (AMPT). Despite perfusion with AMPT, the ability of ephedrine to cause hyperpolarization was restored after perfusing the slice with dopamine (30 microM). Taken together, these results suggest that ephedrine causes hyperpolarization and suppresses GABAB receptor-mediated effects by releasing endogenous dopamine. However, the high concentrations required to observe these effects in vitro suggest that biologically relevant central effects of ephedrine are more likely to be mediated either by non-dopamine systems, such as those involving noradrenaline, or by dopamine systems outside the SNC.

Mesh Headings (Keywords): Action Potentials, Animals, Baclofen, Central Nervous System Stimulants, Dopamine, Dopamine Antagonists, Dose-Response Relationship, Drug, Drug Interactions, Enzyme Inhibitors, Ephedrine, GABA Agonists, GABA Antagonists, Male, Organophosphorus Compounds, Rats, Rats, Sprague-Dawley, Substantia Nigra, Sulpiride, alpha-Methyltyrosine


Check for Full Text / PubMed Unique Identifier (PMID): 16386715


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.